For research use only. Not for therapeutic Use.
Reltecimod TFA(CAT: I040980) is a potent CD28 antagonist peptide, designed to modulate T-cell activation and immune response. It functions by inhibiting CD28-mediated co-stimulation, making it a valuable tool for research in inflammatory diseases, sepsis, and immune modulation therapies. Reltecimod has been investigated for its potential in reducing hyperinflammatory responses in severe infections and other immune disorders. The trifluoroacetate (TFA) salt form ensures high stability and solubility for biochemical, cellular, and preclinical studies. Ideal for studying immune regulation and inflammation control, this compound is for research use only; not for human or clinical applications.
| Molecular Formula | C46H72N10O15S.xC2HF3O2 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
